Table 1 |
||||
|
Anal cancer RR (95% CI) for HIV+ MSM and HIV+ non-MSM compared with HIV- controls (reference) and national US SEER rates. |
||||
|
RR (MSM) |
RR (non-MSM) |
SIR (MSM) |
SIR (non-MSM) |
|
|
|
||||
|
1996 to 1998 |
97.7 (12.3-774.3) |
12.0 (0.7-195.5) |
63.5 (29.0-120.6) |
10.2 (0.3-56.9) |
|
1999 to 2002 |
114.7 (35.3-372.8) |
35.2 (9.8-126.5) |
117.3 (84.5-158.5) |
26.4 (11.4-52.0) |
|
2003 to 2007 |
48.1 (23.6-98.2) |
19.7 (8.8-44.1) |
77.7 (59.3-100.0) |
26.4 (14.8-43.5) |
|
|
||||
|
Silverberg et al. Infectious Agents and Cancer 2010 5(Suppl 1):A70 doi:10.1186/1750-9378-5-S1-A70 |
||||